| Name | Traded | Action | Notifier | Last | Amount | Value |
|---|---|---|---|---|---|---|
| GSK | 21-Feb-25 | Buy | Hal Barron | 3,664.00p | 3,269,946 | £119,810,819.44 |
| GSK | 16-Apr-24 | Buy Dividends | Hal Barron | $39.79 | 2,906,213 | $95,366,062.48 |
| GSK | 16-Apr-24 | Buy Dividends | Emma Walmsley | 1,611.28p | 1,840,922 | £29,662,409.10 |
| Allergy Therapeutics | 14-Jan-25 | Exercise of option | Zheqing Shen | 4.00p | 457,937,504 | £18,317,499.75 |
| Allergy Therapeutics | 14-Jan-25 | Exercise of option | Anthony Parker | 4.00p | 229,562,496 | £9,182,499.63 |
| Destiny Pharma | 02-Aug-24 | Buy | Nigel Rudd | 250.00p | 1,240,000 | £3,100,000.00 |
| Oxford Nanopore Technologies | 15-Oct-24 | Sell | Gurdial (Gordon) Sanghera | 141.66p | 1,993,571 | £2,824,112.62 |
| AstraZeneca | 14-Nov-24 | Buy | Pascal Soriot | 10,203.00p | 20,000 | £2,040,599.98 |
| Animalcare Group | 05-Dec-24 | Buy | Marc Coucke | 232.50p | 860,213 | £1,999,995.27 |
| GSK | 10-Feb-25 | Sell | Emma Walmsley | 1,453.19p | 120,653 | £1,753,317.38 |
| Oxford Nanopore Technologies | 28-Jun-24 | Sell | Gurdial (Gordon) Sanghera | 91.64p | 1,203,967 | £1,103,357.50 |
| OptiBiotix Health | 17-Dec-24 | Exercise of option | Stephen O'Hara | 16.00p | 6,099,135 | £975,861.58 |
| Argent Biopharma Limited NPV (DI) | 15-Oct-24 | Placing | Roby Zomer | $0.41 | 4,000,000 | $868,046.36 |
| GSK | 18-Feb-25 | Sell | Hal Barron | $36.64 | 24,623 | $743,857.48 |
| 4basebio | 15-Nov-24 | Buy | Heikki Lanckriet | 1,325.00p | 46,500 | £616,125.00 |
| 4basebio | 15-Nov-24 | Sell | Heikki Lanckriet | 1,325.00p | 46,500 | £616,125.00 |
| PureTech Health | 24-Jun-24 | Sell | Robert Langer | 250.00p | 233,098 | £582,745.00 |
| GSK | 17-Feb-25 | Sell | Emma Walmsley | 1,418.18p | 38,459 | £545,417.84 |
| Indivior | 27-Feb-25 | Buy | Robert Schriesheim | $8.56 | 58,833 | $415,493.80 |
| Indivior | 27-Feb-25 | Buy | Joe Ciaffoni | $8.96 | 56,000 | $413,555.86 |